カテゴリ： MarketsandMarkets, 世界, 医療/バイオ

世界の生細胞イメージング市場（〜2028年）：製品別（機器、消耗品、ソフトウェア、サービス）、用途別（細胞生物学、幹細胞、創薬）、技術別（タイムラプス顕微鏡検査法、FRET、FRAP、HCS）、エンドユーザー別（製薬、バイオテクノロジー、CRO）

■ 英語タイトル：Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), Technology (Time-lapse Microscopy, FRET, FRAP, HCS), End User (Pharma, Biotech, CROs) - Global Forecast to 2028

調査会社MarketsandMarkets社が発行したリサーチレポート（データ管理コード：BT3390-23）■ 発行会社/調査会社：MarketsandMarkets
■ 商品コード：BT3390-23
■ 発行日：2023年5月30日
■ 調査対象地域：グローバル
■ 産業分野：バイオ
■ ページ数：293
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥1,010,800見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,238,800見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の生細胞イメージング市場（〜2028年）：製品別（機器、消耗品、ソフトウェア、サービス）、用途別（細胞生物学、幹細胞、創薬）、技術別（タイムラプス顕微鏡検査法、FRET、FRAP、HCS）、エンドユーザー別（製薬、バイオテクノロジー、CRO）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

MarketsandMarkets社の本調査レポートでは、世界の生細胞イメージング市場規模が2023年の27億ドルから2028年までに43億ドルに拡大し、予測期間中に年平均10.2%で成長すると予想しています。本書では、生細胞イメージングの世界市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別（機器、消耗品、ソフトウェア、サービス）分析、用途別（細胞生物学、幹細胞、発達生物学、創薬）分析、技術別（タイムラプス顕微鏡検査法、FRET、FRAP、HCS、その他）分析、エンドユーザー別（製薬・バイオテクノロジー企業、学術・研究機関、CRO）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況、企業情報、隣接・関連市場などの内容を掲載しています。また、参入企業情報として、Danaher（US）、ZEISS Group（Germany）、Nikon Corporation（Japan）、Olympus Corporation（Japan）、PerkinElmer Inc.（US）、Sartorius AG（Germany）、Agilent Technologies Inc.（US）などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の生細胞イメージング市場規模：製品別
- 機器の市場規模
- 消耗品の市場規模
- ソフトウェアの市場規模
- サービスの市場規模
・世界の生細胞イメージング市場規模：用途別
- 細胞生物学における市場規模
- 幹細胞における市場規模
- 発達生物学における市場規模
- 創薬における市場規模
・世界の生細胞イメージング市場規模：技術別
- タイムラプス顕微鏡検査法における市場規模
- FRETにおける市場規模
- FRAPにおける市場規模
- HCSにおける市場規模
- その他技術における市場規模
・世界の生細胞イメージング市場規模：エンドユーザー別
- 製薬・バイオテクノロジー企業における市場規模
- 学術・研究機関における市場規模
- CROにおける市場規模
・世界の生細胞イメージング市場規模：地域別
- 北米の生細胞イメージング市場規模
- ヨーロッパの生細胞イメージング市場規模
- アジア太平洋の生細胞イメージング市場規模
- 中南米の生細胞イメージング市場規模
- 中東・アフリカの生細胞イメージング市場規模
・競争状況
・企業情報
・隣接・関連市場

“世界の生細胞イメージング市場は、2023年の27億米ドルから2028年には43億米ドルに達し、2023年から2028年の予測期間中の年平均成長率は10.2%と予想”
この市場の成長は、創薬におけるハイコンテントスクリーニング技術の採用率の増加に起因しています。創薬におけるハイスループットスクリーニングやHCS技術への依存度が高まるにつれて、生細胞イメージング技術に対する需要は拡大すると考えられます。この傾向は、個々の患者に合わせた治療法を特定するために生細胞イメージングを使用できる個別化医療の分野で特に顕著になると予想されます。

“予測期間中、消耗品セグメントが製品・サービス別シェア第2位”
2022年、世界の生細胞イメージング市場において、消耗品セグメントは製品・サービス別で2番目に大きなシェアを占めました。消耗品には、生細胞イメージングや分析に使用されるさまざまな製品が含まれます。これらの消耗品は、サンプルの前処理、メンテナンス、分析に不可欠であるため、生細胞イメージングのワークフローにおいて重要な役割を果たしています。生細胞イメージングに使用される消耗品には、試薬、培地、アッセイキット、マイクロプレート、スライド、シャーレ、カバースリップ、培養チャンバーなどの消耗品が含まれます。消耗品は通常使い捨てで、定期的に補充する必要があるため、メーカーにとっては重要な経常収益の柱となっています。消耗品は生細胞イメージングに不可欠な要素であり、このセグメントの成長は、主に高度なイメージング技術に対する需要の増加と、様々な研究用途におけるライブセル解析の採用拡大によってもたらされます。

“欧州：生細胞イメージング市場で2番目に大きい地域”
欧州は北米に次いで生細胞イメージング市場で2番目の規模を占めています。欧州の生細胞イメージング市場は、その拡大を後押しする様々な要因によって、近年著しい成長を遂げています。欧州は、生細胞イメージング分野における新技術の開発と導入の最前線にあります。これには、超解像顕微鏡、ハイスループットイメージング、シングルセルイメージング、マルチモーダルイメージングアプローチの進歩が含まれます。これらの革新的な技術の採用は、生細胞イメージング研究の進展を加速し、その応用を拡大します。さらに、欧州では生細胞イメージング技術に関する包括的なトレーニングや教育プログラムを提供しています。大学、研究機関、組織は、科学者や研究者の知識やスキルを向上させるための専門コース、ワークショップ、会議を開催しています。欧州ではトレーニングプログラムが充実しているため、生細胞イメージング技術の採用と利用が促進されています。

本レポートのために実施した一次インタビューは以下のように分類されます：
– 回答者別 供給側80％、需要側20％
– 役職別 Cレベル：45%、Dレベル：30%、その他：25％
– 地域別 北米20％、欧州10％、アジア太平洋55％、中南米10％、中東・アフリカ5％

レポート掲載企業一覧
• Danaher (US)
• ZEISS Group (Germany)
• Nikon Corporation (Japan)
• Olympus Corporation (Japan)
• PerkinElmer Inc. (US)
• Sartorius AG (Germany)
• Agilent Technologies, Inc. (US)
• Thermo Fisher Scientific, Inc. (US)
• Etaluma, Inc. (US)
• CytoSMART Technologies (Netherlands)
• NanoEnTek Inc. (South Korea)
• GE Healthcare (US)
• Bruker Corporation (US)
• Becton, Dickinson and Company (BD) (US)
• Merck KGaA (Germany)
• Bio-Rad Laboratories, Inc. (US)
• Blue-Ray Biotech Corp. (Taiwan)
• CYTENA GmbH (Germany)
• Nanolive SA (Switzerland)
• Abberior (Germany)
• Phase Holographic Imaging (PHI) AB (Sweden)
• Cytoskeleton, Inc. (US)
• Corning Incorporated (US)
• KEYENCE Corporation (Japan)
• Aligned Genetics, Inc. (South Korea)

調査範囲
この調査レポートは、生細胞イメージング市場の詳細な情報を提供しています。製品・サービス、用途、技術、エンドユーザー、地域など、さまざまなセグメントにわたる市場規模と今後の成長可能性を推定することを目的としています。また、主要市場プレイヤーの企業プロフィールや最近の動向、主要市場戦略とともに、詳細な競合分析も掲載しています。

レポート購入の主な利点
本レポートは、市場全体とそのサブセグメントにおける収益数の最も近い概算値を提供することで、市場リーダー/新規参入者を支援します。また、利害関係者が競争状況をよりよく理解し、自社のビジネスをよりよく位置づけ、適切な市場参入戦略を立てるための洞察を深めるのにも役立ちます。本レポートは、関係者が市場動向を理解し、主要な市場促進要因、阻害要因、機会、および課題に関する情報を提供することを可能にします。

本レポートは、以下のポイントに関する洞察を提供します：
– 市場成長に影響を与える主要促進要因（創薬におけるハイコンテントスクリーニング技術の採用拡大、癌罹患率の上昇、研究資金の増加）、阻害要因（ハイコンテントスクリーニングシステムの高コスト）、機会（新興市場における生細胞イメージング技術の採用拡大、個別化医療におけるHCSの応用）、課題（細胞培養における細胞生存率と細胞環境の維持、画像解析とデータ管理）分析
– 製品とサービスの開発／革新： 新たに発売された製品・サービスに関する詳細な洞察、生細胞イメージング市場の技術評価
– 市場開発： 有利な市場に関する包括的な情報 – 当レポートでは様々な地域の市場を分析
– 市場の多様化： 生細胞イメージング市場における新製品やサービス、未開拓の地域、最近の開発、投資に関する詳細情報
– 競合評価： Danaher (US), ZEISS Group (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer Inc. (US), Sartorius AG (Germany), Agilent Technologies, Inc. (US), Thermo Fisher Scientific, Inc. (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), NanoEnTek Inc. (South Korea), GE Healthcare (US), Bruker Corporation (US), Becton, Dickinson and Company (BD) (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Blue-Ray Biotech Corp. (Taiwan), CYTENA GmbH (Germany), Nanolive SA (Switzerland), Abberior (Germany), Phase Holographic Imaging (PHI) AB (Sweden), Cytoskeleton, Inc. (US), Corning Incorporated (US), KEYENCE Corporation (Japan), Aligned Genetics, Inc. (South Korea)など、主要企業の市場シェア、成長戦略、大手企業の製品とサービスを詳細に評価

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 INTRODUCTION 41
1.1 STUDY OBJECTIVES 41
1.2 MARKET DEFINITION 41
1.2.1 INCLUSIONS & EXCLUSIONS 42
1.3 MARKET SCOPE 42
FIGURE 1 LIVE CELL IMAGING MARKET SEGMENTATION 42
1.3.1 YEARS CONSIDERED 43
1.4 CURRENCY 43
1.5 LIMITATIONS 43
1.6 STAKEHOLDERS 44
1.7 SUMMARY OF CHANGES 44
1.7.1 RECESSION IMPACT 45
2 RESEARCH METHODOLOGY 46
2.1 RESEARCH DATA 46
FIGURE 2 RESEARCH DESIGN 46
2.1.1 SECONDARY DATA 47
2.1.2 PRIMARY DATA 47
FIGURE 3 LIVE CELL IMAGING MARKET: BREAKDOWN OF PRIMARIES 48
2.2 MARKET SIZE ESTIMATION 49
FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022 49
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022 50
FIGURE 6 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE SHARE ANALYSIS, 2022 51
2.2.1 INSIGHTS FROM PRIMARIES 52
FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS 52
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 52
2.3 GROWTH FORECAST 53
FIGURE 9 LIVE CELL IMAGING MARKET: CAGR PROJECTIONS, 2022–2028 54
FIGURE 10 LIVE CELL IMAGING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 55
FIGURE 11 DATA TRIANGULATION METHODOLOGY 55
2.5 RESEARCH ASSUMPTIONS 56
2.6 RISK ANALYSIS 56
2.7 RECESSION IMPACT ON LIVE CELL IMAGING MARKET 56
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 57
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 57
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 57
3 EXECUTIVE SUMMARY 59
FIGURE 12 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 59
FIGURE 13 LIVE CELL IMAGING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 60
FIGURE 14 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 60
FIGURE 15 LIVE CELL IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 61
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF LIVE CELL IMAGING MARKET 62
4 PREMIUM INSIGHTS 63
4.1 LIVE CELL IMAGING MARKET OVERVIEW 63
FIGURE 17 GROWING ADOPTION OF HIGH-CONTENT SCREENING TECHNIQUES IN DRUG DISCOVERY TO DRIVE MARKET GROWTH 63
4.2 NORTH AMERICA: LIVE CELL IMAGING MARKET SHARE, BY PRODUCT & SERVICE AND COUNTRY (2022) 64
FIGURE 18 INSTRUMENTS DOMINATED NORTH AMERICAN LIVE CELL IMAGING MARKET IN 2022 64
4.3 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 65
FIGURE 19 INSTRUMENTS TO CONTINUE TO DOMINATE MARKET BY 2028 65
4.4 LIVE CELL IMAGING MARKET SHARE, BY END USER, 2022 65
FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 65
4.5 LIVE CELL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 66
FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN LIVE CELL IMAGING MARKET FROM 2023 TO 2028 66
5 MARKET OVERVIEW 67
5.1 INTRODUCTION 67
5.2 MARKET DYNAMICS 67
FIGURE 22 LIVE CELL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 67
TABLE 4 LIVE CELL IMAGING MARKET: IMPACT ANALYSIS 68
5.2.1 DRIVERS 68
5.2.1.1 Growing adoption of high-content screening techniques in drug discovery 68
5.2.1.2 Rising incidence of cancer 69
TABLE 5 ESTIMATED NEW CANCER CASES IN US, 2023 69
FIGURE 23 GLOBAL CANCER INCIDENCE & MORTALITY, 2020 70
5.2.1.3 Growing availability of research funds 70
TABLE 6 INVESTMENT BREAKDOWN, 2021 (USD MILLION) 72
5.2.2 RESTRAINTS 72
5.2.2.1 High cost of high-content screening systems 72
5.2.3 OPPORTUNITIES 73
5.2.3.1 Increasing adoption of live cell imaging technologies in emerging economies 73
5.2.3.2 Applications of HCS in personalized medicine 73
5.2.4 CHALLENGES 74
5.2.4.1 Maintaining cell viability and cellular environment in cell cultures 74
5.2.4.2 Image analysis and data management 74
5.3 TECHNOLOGY ANALYSIS 75
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 76
FIGURE 24 REVENUE SHIFT & NEW POCKETS FOR LIVE CELL IMAGING PRODUCT & SERVICE PROVIDERS 77
5.5 VALUE/SUPPLY CHAIN ANALYSIS 77
5.5.1 VALUE CHAIN ANALYSIS 77
FIGURE 25 LIVE CELL IMAGING MARKET: VALUE CHAIN ANALYSIS 78
5.5.2 SUPPLY CHAIN ANALYSIS 79
FIGURE 26 LIVE CELL IMAGING MARKET: SUPPLY CHAIN ANALYSIS 79
5.6 REGULATORY ANALYSIS 80
5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
5.6.1.1 North America 80
5.6.1.1.1 US 80
5.6.1.1.2 Canada 80
5.6.1.2 Europe 80
5.6.1.3 Asia Pacific 81
5.6.1.4 Rest of the World 81
5.7 PORTER’S FIVE FORCES ANALYSIS 82
TABLE 7 LIVE CELL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 82
5.7.1 THREAT OF NEW ENTRANTS 82
5.7.2 THREAT OF SUBSTITUTES 82
5.7.3 BARGAINING POWER OF SUPPLIERS 82
5.7.4 BARGAINING POWER OF BUYERS 82
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 83
5.8 ECOSYSTEM ANALYSIS 83
TABLE 8 SUPPLY CHAIN ECOSYSTEM 83
5.9 PRICING ANALYSIS 85
5.9.1 AVERAGE SELLING PRICE, BY KEY PLAYER 85
TABLE 9 AVERAGE SELLING PRICES 85
5.9.2 AVERAGE SELLING PRICE TREND 86
5.10 KEY CONFERENCES & EVENTS IN 2022–2023 86
TABLE 10 LIVE CELL IMAGING: DETAILED LIST OF CONFERENCES & EVENTS 86
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 88
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 88
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF LIVE CELL IMAGING PRODUCTS 88
5.11.2 BUYING CRITERIA FOR LIVE CELL IMAGING 88
FIGURE 28 KEY BUYING CRITERIA FOR END USERS 88
5.12 PATENT ANALYSIS 89
FIGURE 29 LIVE CELL IMAGING MARKET: PATENT APPLICATIONS (JANUARY 2020–APRIL 2023) 89
6 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE 90
6.1 INTRODUCTION 91
TABLE 11 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 91
6.2 INSTRUMENTS 92
TABLE 12 EXAMPLES OF INSTRUMENTS OFFERED BY MARKET PLAYERS 92
TABLE 13 LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 93
TABLE 14 LIVE CELL IMAGING INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 93
TABLE 15 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 16 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 17 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 18 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
6.2.1 MICROSCOPES 95
6.2.1.1 Continuous technological advancements in microscopes to support market 95
TABLE 19 CONVENTIONAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS 96
TABLE 20 CONFOCAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS 97
TABLE 21 FLUORESCENCE MICROSCOPES OFFERED BY KEY MARKET PLAYERS 98
TABLE 22 LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY REGION, 2021–2028 (USD MILLION) 98
TABLE 23 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 24 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 25 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 26 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION) 100
6.2.2 STANDALONE SYSTEMS 100
6.2.2.1 Seamless integration and workflow efficiency of standalone systems to boost demand 100
TABLE 27 STANDALONE SYSTEMS OFFERED BY KEY MARKET PLAYERS 100
TABLE 28 LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY REGION, 2021–2028 (USD MILLION) 101
TABLE 29 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 30 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 31 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 32 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 102
6.2.3 CELL ANALYZERS 102
6.2.3.1 Accuracy and reproducibility of cell analyzers to support growth 102
TABLE 33 CELL ANALYZERS OFFERED BY KEY MARKET PLAYERS 103
TABLE 34 LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY REGION, 2021–2028 (USD MILLION) 103
TABLE 35 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 36 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 37 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 38 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 104
6.2.4 ACCESSORIES 105
6.2.4.1 Ability of accessories to optimize and enhance imaging conditions to boost demand 105
TABLE 39 ACCESSORIES OFFERED BY KEY MARKET PLAYERS 105
TABLE 40 LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY REGION, 2021–2028 (USD MILLION) 106
TABLE 41 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 42 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 43 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 44 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION) 107
6.3 CONSUMABLES 108
TABLE 45 LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 108
TABLE 46 LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 108
TABLE 47 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 48 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 49 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 50 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
6.3.1 REAGENTS 110
6.3.1.1 Widespread usage in life science research to fuel market growth 110
TABLE 51 REAGENTS OFFERED BY KEY MARKET PLAYERS 111
TABLE 52 LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY REGION, 2021–2028 (USD MILLION) 111
TABLE 53 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 54 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 55 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 56 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 113
6.3.2 ASSAY KITS 113
6.3.2.1 Repeat purchase of assay kits to drive market 113
TABLE 57 ASSAY KITS OFFERED BY KEY MARKET PLAYERS 113
TABLE 58 LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 59 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 60 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 61 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 62 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION) 115
6.3.3 MEDIA 116
6.3.3.1 Increasing demand for optimized cell culture conditions to drive demand for media 116
TABLE 63 MEDIA OFFERED BY KEY MARKET PLAYERS 116
TABLE 64 LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY REGION, 2021–2028 (USD MILLION) 116
TABLE 65 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 66 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 67 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 68 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION) 118
6.3.4 OTHER CONSUMABLES 118
TABLE 69 OTHER CONSUMABLES OFFERED BY KEY MARKET PLAYERS 119
TABLE 70 OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 119
TABLE 71 NORTH AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
TABLE 72 EUROPE: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 73 ASIA PACIFIC: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 74 LATIN AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
6.4 SOFTWARE 121
6.4.1 TECHNOLOGICAL ADVANCEMENTS IN IMAGE ACQUISITION TO BOOST MARKET GROWTH 121
TABLE 75 SOFTWARE OFFERED BY KEY MARKET PLAYERS 121
TABLE 76 LIVE CELL IMAGING SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION) 122
TABLE 77 NORTH AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 78 EUROPE: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 79 ASIA PACIFIC: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 80 LATIN AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
6.5 SERVICES 124
6.5.1 GROWING DEMAND FOR OUTSOURCED EXPERTISE AND SPECIALIZED SERVICES TO SUPPORT MARKET 124
TABLE 81 LIVE CELL IMAGING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 124
TABLE 82 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 83 EUROPE: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 84 ASIA PACIFIC: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 85 LATIN AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
7 LIVE CELL IMAGING MARKET, BY APPLICATION 127
7.1 INTRODUCTION 128
TABLE 86 LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 128
7.2 CELL BIOLOGY 128
TABLE 87 NUMBER OF NEW CANCER CASES, BY TYPE, 2020 VS. 2040 129
TABLE 88 LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 130
TABLE 89 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 90 EUROPE: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 91 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 92 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 131
7.3 STEM CELLS 131
7.3.1 GROWING FOCUS ON REGENERATIVE MEDICINE & ADVANCEMENTS IN STEM CELL RESEARCH TO BOOST MARKET 131
TABLE 93 LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 132
TABLE 94 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 95 EUROPE: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 133
TABLE 96 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 133
TABLE 97 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 133
7.4 DEVELOPMENTAL BIOLOGY 134
7.4.1 GROWING INTEREST IN UNDERSTANDING ORGANOGENESIS AND TISSUE MORPHOGENESIS TO DRIVE DEMAND 134
TABLE 98 LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 134
TABLE 99 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 100 EUROPE: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 101 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 102 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 136
7.5 DRUG DISCOVERY 136
7.5.1 GROWING USE OF HCS CELL-BASED ASSAYS IN DRUG DISCOVERY STUDIES TO DRIVE DEMAND 136
TABLE 103 LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 137
TABLE 104 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 105 EUROPE: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 106 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 107 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 138
8 LIVE CELL IMAGING MARKET, BY TECHNOLOGY 139
8.1 INTRODUCTION 140
TABLE 108 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 140
8.2 TIME-LAPSE MICROSCOPY 140
TABLE 109 LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY REGION, 2021–2028 (USD MILLION) 141
TABLE 110 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 111 EUROPE: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 112 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 113 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION) 142
8.3 FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET) 143
8.3.1 ADVANCEMENTS IN FLUORESCENT MATERIALS AND PROBES TO BOOST ADOPTION OF FRET TECHNOLOGY 143
TABLE 114 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY REGION, 2021–2028 (USD MILLION) 143
TABLE 115 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 116 EUROPE: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 117 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 118 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION) 144
8.4 FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING (FRAP) 145
8.4.1 INTEGRATION OF FRAP WITH LIVE CELL IMAGING MICROSCOPY TO CONTRIBUTE TO MARKET GROWTH 145
TABLE 119 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY REGION, 2021–2028 (USD MILLION) 145
TABLE 120 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 121 EUROPE: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 122 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 123 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION) 147
8.5 HIGH-CONTENT SCREENING (HCS) 147
8.5.1 GROWING ADOPTION OF HCS IN DRUG DISCOVERY AND TOXICITY SCREENING TO DRIVE GROWTH 147
TABLE 124 LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY REGION, 2021–2028 (USD MILLION) 148
TABLE 125 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 126 EUROPE: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 127 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 128 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 149

8.6 OTHER TECHNOLOGIES 149
TABLE 129 LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION) 150
TABLE 130 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 131 EUROPE: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 132 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 133 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 151
9 LIVE CELL IMAGING MARKET, BY END USER 152
9.1 INTRODUCTION 153
TABLE 134 LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 153
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 153
9.2.1 NEED TO ADHERE TO STRICT REGULATIONS TO DRIVE USE OF LIVE CELL IMAGING PRODUCTS AMONG PHARMA COMPANIES 153
TABLE 135 LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 154
TABLE 136 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 137 EUROPE: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 155
TABLE 138 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 155
TABLE 139 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 155
9.3 ACADEMIC & RESEARCH INSTITUTES 156
9.3.1 INCREASING NUMBER OF DRUG DISCOVERY RESEARCH PROGRAMS TO DRIVE MARKET GROWTH 156
TABLE 140 LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 156
TABLE 141 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 142 EUROPE: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 143 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 144 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 158
9.4 CONTRACT RESEARCH ORGANIZATIONS 158
9.4.1 GROWING OUTSOURCING OF R&D ACTIVITIES BY PHARMACEUTICAL COMPANIES TO DRIVE DEMAND 158
TABLE 145 LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021–2028 (USD MILLION) 159
TABLE 146 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 159
TABLE 147 EUROPE: LIVE CELL IMAGING MARKET FOR F CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 148 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 149 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 160
10 LIVE CELL IMAGING MARKET, BY REGION 161
10.1 INTRODUCTION 162
TABLE 150 LIVE CELL IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION) 162
10.2 NORTH AMERICA 162
FIGURE 30 NORTH AMERICA: LIVE CELL IMAGING MARKET SNAPSHOT 163
TABLE 151 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 152 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 164
TABLE 153 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 154 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 155 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 165
TABLE 156 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 166
TABLE 157 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 166
10.2.1 US 167
10.2.1.1 US to dominate live cell imaging market in North America 167
TABLE 158 US: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 167
TABLE 159 US: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 160 US: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 161 US: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 168
TABLE 162 US: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 169
TABLE 163 US: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 169
10.2.2 CANADA 169
10.2.2.1 Government initiatives to promote research to support market growth 169
TABLE 164 CANADA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 170
TABLE 165 CANADA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 166 CANADA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 167 CANADA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 171
TABLE 168 CANADA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 171
TABLE 169 CANADA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 172
10.2.3 NORTH AMERICA: RECESSION IMPACT 172
10.3 EUROPE 173
TABLE 170 EUROPE: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 171 EUROPE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 174
TABLE 172 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 173 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 174 EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 175
TABLE 175 EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 175
TABLE 176 EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 176
10.3.1 GERMANY 176
10.3.1.1 Presence of large number of academic research institutes to boost market 176
TABLE 177 GERMANY: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 177
TABLE 178 GERMANY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 179 GERMANY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 180 GERMANY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 178
TABLE 181 GERMANY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 179
TABLE 182 GERMANY: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 179
10.3.2 UK 180
10.3.2.1 Investments by pharmaceutical sponsors for drug discovery services to support market 180
FIGURE 31 UK: PHARMACEUTICAL R&D EXPENDITURE, 2011–2020 (USD MILLION) 180
TABLE 183 UK: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 181
TABLE 184 UK: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 185 UK: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 186 UK: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 182
TABLE 187 UK: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 182
TABLE 188 UK: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 183
10.3.3 FRANCE 183
10.3.3.1 Large pharmaceutical manufacturing industry to drive market growth 183
TABLE 189 FRANCE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 184
TABLE 190 FRANCE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 191 FRANCE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 192 FRANCE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 185
TABLE 193 FRANCE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 186
TABLE 194 FRANCE: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 186
10.3.4 ITALY 186
10.3.4.1 Strong research tradition, government funding, and collaborative research networks to fuel growth 186
TABLE 195 ITALY: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 187
TABLE 196 ITALY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 197 ITALY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 198 ITALY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 188
TABLE 199 ITALY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 189
TABLE 200 ITALY: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 189
10.3.5 SPAIN 190
10.3.5.1 Rising R&D expenditure to boost market 190
TABLE 201 SPAIN: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 190
TABLE 202 SPAIN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 203 SPAIN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 204 SPAIN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 191
TABLE 205 SPAIN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 192
TABLE 206 SPAIN: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 192
10.3.6 REST OF EUROPE 192
TABLE 207 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 193
TABLE 208 REST OF EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 209 REST OF EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 194
TABLE 210 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 194
TABLE 211 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 195
TABLE 212 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 195
10.3.7 EUROPE: RECESSION IMPACT 196

10.4 ASIA PACIFIC 196
TABLE 213 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 197
TABLE 214 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 197
TABLE 215 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 216 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 217 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 198
TABLE 218 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 199
TABLE 219 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 199
10.4.1 CHINA 200
10.4.1.1 China to dominate APAC live cell imaging market 200
TABLE 220 CHINA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 200
TABLE 221 CHINA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 222 CHINA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 223 CHINA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 201
TABLE 224 CHINA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 202
TABLE 225 CHINA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 202
10.4.2 JAPAN 202
10.4.2.1 Rising prominence of regenerative medicine research to drive market growth 202
TABLE 226 JAPAN: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 203
TABLE 227 JAPAN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 228 JAPAN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 229 JAPAN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 204
TABLE 230 JAPAN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 205
TABLE 231 JAPAN: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 205
10.4.3 INDIA 206
10.4.3.1 Growing pharmaceutical industry to create favorable opportunities for market players 206
TABLE 232 INDIA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 206
TABLE 233 INDIA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 234 INDIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 235 INDIA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 207
TABLE 236 INDIA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 208
TABLE 237 INDIA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 208
10.4.4 REST OF ASIA PACIFIC (ROAPAC) 208
TABLE 238 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 209
TABLE 239 REST OF ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 240 REST OF ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 241 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 211
TABLE 242 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 211
TABLE 243 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 212
10.4.5 ASIA PACIFIC: RECESSION IMPACT 212
10.5 LATIN AMERICA 212
TABLE 244 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 213
TABLE 245 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 213
TABLE 246 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 247 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 248 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 214
TABLE 249 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 215
TABLE 250 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 215
10.5.1 BRAZIL 216
10.5.1.1 Gradual growth in research to contribute to growth 216
TABLE 251 BRAZIL: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 216
TABLE 252 BRAZIL: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 216
TABLE 253 BRAZIL: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 254 BRAZIL: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 217
TABLE 255 BRAZIL: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 218
TABLE 256 BRAZIL: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 218
10.5.2 REST OF LATIN AMERICA 219
TABLE 257 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 219
TABLE 258 REST OF LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 259 REST OF LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 220
TABLE 260 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 220
TABLE 261 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 221
TABLE 262 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 221
10.5.3 LATIN AMERICA: RECESSION IMPACT 222
10.6 MIDDLE EAST & AFRICA 222
10.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET GROWTH 222
TABLE 263 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 223
TABLE 264 MIDDLE EAST & AFRICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 265 MIDDLE EAST & AFRICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 266 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 224
TABLE 267 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 224
TABLE 268 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 225
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 225
11 COMPETITIVE LANDSCAPE 226
11.1 INTRODUCTION 226
11.2 STRATEGIES ADOPTED BY KEY PLAYERS 227
FIGURE 32 LIVE CELL IMAGING MARKET: STRATEGIES ADOPTED BY KEY PLAYERS 227
11.3 REVENUE SHARE ANALYSIS 228
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022 228
11.4 MARKET SHARE ANALYSIS 228
FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022 229
TABLE 269 LIVE CELL IMAGING MARKET: DEGREE OF COMPETITION 229
11.5 COMPANY EVALUATION QUADRANT: KEY PLAYERS 230
FIGURE 35 LIVE CELL IMAGING MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 231
11.5.1 STARS 232
11.5.2 EMERGING LEADERS 232
11.5.3 PERVASIVE PLAYERS 232
11.5.4 PARTICIPANTS 232
11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 233
11.6.1 END-USER FOOTPRINT OF COMPANIES (25 COMPANIES) 233
TABLE 270 END-USER FOOTPRINT ANALYSIS OF KEY PLAYERS IN LIVE CELL IMAGING MARKET 233
11.6.2 PRODUCT & SERVICE FOOTPRINT OF COMPANIES (25 COMPANIES) 234
TABLE 271 PRODUCT & SERVICE FOOTPRINT ANALYSIS OF KEY PLAYERS IN LIVE CELL IMAGING MARKET 234
11.6.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES) 235
TABLE 272 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN LIVE CELL IMAGING MARKET 235
11.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES 236
FIGURE 36 LIVE CELL IMAGING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 236
11.7.1 PROGRESSIVE COMPANIES 237
11.7.2 STARTING BLOCKS 237
11.7.3 RESPONSIVE COMPANIES 237
11.7.4 DYNAMIC COMPANIES 237
11.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 237
TABLE 273 LIVE CELL IMAGING MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS 237
TABLE 274 LIVE CELL IMAGING MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 238
11.9 COMPETITIVE SCENARIO AND TRENDS 239
11.9.1 PRODUCT LAUNCHES 239
TABLE 275 LIVE CELL IMAGING MARKET: PRODUCT LAUNCHES, JANUARY 2020–DECEMBER 2022 239
11.9.2 DEALS 240
TABLE 276 LIVE CELL IMAGING MARKET: DEALS, JANUARY 2020–DECEMBER 2022 240
11.9.3 OTHER DEVELOPMENTS 241
TABLE 277 LIVE CELL IMAGING MARKET: OTHER DEVELOPMENTS, JANUARY 2020–DECEMBER 2022 241
12 COMPANY PROFILES 242
12.1 KEY COMPANIES 242
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER 242
TABLE 278 DANAHER: BUSINESS OVERVIEW 242
FIGURE 37 DANAHER: COMPANY SNAPSHOT (2022) 243
12.1.2 ZEISS GROUP 247
TABLE 279 ZEISS GROUP: BUSINESS OVERVIEW 247
FIGURE 38 ZEISS GROUP: COMPANY SNAPSHOT (2022) 248
12.1.3 SARTORIUS AG 251
TABLE 280 SARTORIUS AG: BUSINESS OVERVIEW 251
FIGURE 39 SARTORIUS AG: COMPANY SNAPSHOT (2022) 252
12.1.4 THERMO FISHER SCIENTIFIC, INC. 254
TABLE 281 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 254
FIGURE 40 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022) 255
12.1.5 OLYMPUS CORPORATION 257
TABLE 282 OLYMPUS CORPORATION: BUSINESS OVERVIEW 257
FIGURE 41 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022) 258
12.1.6 PERKINELMER INC. 260
TABLE 283 PERKINELMER INC.: BUSINESS OVERVIEW 260
FIGURE 42 PERKINELMER INC.: COMPANY SNAPSHOT (2023) 261
12.1.7 NIKON CORPORATION 263
TABLE 284 NIKON CORPORATION: BUSINESS OVERVIEW 263
FIGURE 43 NIKON CORPORATION: COMPANY SNAPSHOT (2022) 264
12.1.8 ETALUMA, INC. 267
TABLE 285 ETALUMA, INC.: BUSINESS OVERVIEW 267
12.1.9 CYTOSMART TECHNOLOGIES 269
TABLE 286 CYTOSMART TECHNOLOGIES.: BUSINESS OVERVIEW 269
12.1.10 AGILENT TECHNOLOGIES, INC. 271
TABLE 287 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 271
FIGURE 44 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022) 272
12.1.11 NANOENTEK INC. 274
12.1.12 BECTON, DICKINSON AND COMPANY 275
TABLE 288 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 275
FIGURE 45 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 276
12.1.13 GE HEALTHCARE 277
TABLE 289 GE HEALTHCARE: BUSINESS OVERVIEW 277
FIGURE 46 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 278
12.1.14 BRUKER CORPORATION 279
TABLE 290 BRUKER CORPORATION: BUSINESS OVERVIEW 279
FIGURE 47 BRUKER CORPORATION: COMPANY SNAPSHOT (2022) 280
12.1.15 MERCK KGAA 283
TABLE 291 MERCK KGAA: BUSINESS OVERVIEW 283
FIGURE 48 MERCK KGAA: COMPANY SNAPSHOT (2022) 284
12.1.16 BIO-RAD LABORATORIES, INC. 286
TABLE 292 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 286
FIGURE 49 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022) 287
12.1.17 CORNING INCORPORATED 288
TABLE 293 CORNING INCORPORATED: BUSINESS OVERVIEW 288
FIGURE 50 CORNING INCORPORATED: COMPANY SNAPSHOT (2022) 289
12.2 OTHER PLAYERS 290
12.2.1 BLUE-RAY BIOTECH CORP. 290
12.2.2 CYTENA GMBH 290
12.2.3 NANOLIVE SA 291
12.2.4 ABBERIOR 292
12.2.5 PHASE HOLOGRAPHIC IMAGING PHI AB 293
12.2.6 CYTOSKELETON, INC. 294
12.2.7 KEYENCE CORPORATION 295
12.2.8 ALIGNED GENETICS, INC. 296
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 297
13.1 DISCUSSION GUIDE 297
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 301
13.3 CUSTOMIZATION OPTIONS 303
13.4 RELATED REPORTS 304
13.5 AUTHOR DETAILS 305

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のライブセルイメージング（生細胞イメージング）市場（～2030年）：製品別（装置、消耗品、ソフトウェア、サービス）、用途別（細胞生物学、幹細胞、発生生物学、創薬）、技術別（タイムラプス顕微鏡、FRET、FRAP、HCS）、エンドユーザー別（製薬・バイオテクノロジー企業、学術・研究機関、受託研究機関）
  • 世界のハイスループットスクリーニング市場（～2028年）：製品別（機器、消耗品、サービス）、技術別（セルベースアッセイ、ラボオンチップ、ラベルフリー）、用途別（創薬、生命科学研究）、エンドユーザー別（製薬、バイオテクノロジー、CRO）
  • 世界のバイオバンク市場（〜2028年）：製品/サービス別（機器、消耗品、サービス、ソフトウェア）、サンプル別（血液、組織、核酸、細胞株）、所有別、用途別（再生医療、生命科学、臨床研究）、エンドユーザー別
  • 世界の3Dプリント医療機器市場（～2028年）：コンポーネント別（3Dプリンター、3Dバイオプリンター、材料、ソフトウェア、サービス）、技術別（EBM、DMLS、SLS、SLA、DLP、ポリジェット）、用途別（サージカルガイド、補綴物、インプラント）、エンドユーザー別、地域別
  • 世界の細胞解析市場（～2028年）：製品・サービス別（消耗品、機器）、技術別（フローサイトメトリー、PCR、顕微鏡）、プロセス別（計数、生存率、増殖、相互作用、単一細胞解析）、エンドユーザー別（製薬、バイオテクノロジー）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(BT3390-23 )"世界の生細胞イメージング市場（〜2028年）：製品別（機器、消耗品、ソフトウェア、サービス）、用途別（細胞生物学、幹細胞、創薬）、技術別（タイムラプス顕微鏡検査法、FRET、FRAP、HCS）、エンドユーザー別（製薬、バイオテクノロジー、CRO）" (英文：Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), Technology (Time-lapse Microscopy, FRET, FRAP, HCS), End User (Pharma, Biotech, CROs) - Global Forecast to 2028)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。